Literature DB >> 27726827

The ABCs of managing systolic heart failure: Past, present, and future.

Ike Stanley Okwuosa1, Oluseyi Princewill2, Chiemeke Nwabueze3, Lena Mathews2, Steven Hsu2, Nisha A Gilotra4,5, Sabra Lewsey2, Roger S Blumenthal2, Stuart D Russell2.   

Abstract

Heart failure management is complex and constantly evolving. The American College of Cardiology and the American Heart Association (ACC/AHA) last issued evidence-based guidelines in 2013, and since then, new drugs and devices have been developed. This review presents an evidence-based approach to current heart failure management.
Copyright © 2016 Cleveland Clinic.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27726827     DOI: 10.3949/ccjm.83a.16006

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN: 0891-1150            Impact factor:   2.321


  1 in total

Review 1.  Cardiac myosin activators for heart failure therapy: focus on omecamtiv mecarbil.

Authors:  Edgardo Kaplinsky; Gordon Mallarkey
Journal:  Drugs Context       Date:  2018-04-23
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.